Skip to main content

Table 2 Comparison of guidelines for the management of patients with type 2 diabetes mellitus [20, 22]

From: Therapies for type 2 diabetes: lowering HbA1c and associated cardiovascular risk factors

  HbA1c Fasting Glucose Postprandial Glucose Blood Pressure Lipids
AACE/ACE, 2007 [20] ≤ 6.5% Fasting plasma glucose < 110 mg/dL 2-hr postprandial glucose < 140 mg/dL < 130/80 mmHg LDL-C < 100 mg/dL
(< 70 mg/dL for patients with DM and coronary artery disease)
HDL-C >40 mg/dL in men, > 50 mg/dL in women
Triglycerides < 150 mg/dL
ADA, 2009 [22] < 7.0% Preprandial capillary plasma glucose, 70-130 mg/dL Peak postprandial capillary plasma glucose < 180 mg/dL < 130/80 mmHg LDL-C < 100 mg/dL*
HDL-C >40 mg/dL in men, > 50 mg/dL in women
Triglycerides < 150 mg/dL
  1. *In individuals with overt cardiovascular disease, a lower LDL-C goal of < 70 mg/dL (1.8 mmol/L), using high doses of a statin, is an option.
  2. AACE, American Association of Clinical Endocrinologists; ACE, American College of Endocrinology; ADA, American Diabetes Association; DM, diabetes mellitus; HbA1c, glycated hemoglobin; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.